Redox signaling and cancer: the role of "labile" iron

dc.contributor.authorGalaris, D.en
dc.contributor.authorSkiada, V.en
dc.contributor.authorBarbouti, A.en
dc.date.accessioned2015-11-24T18:54:45Z
dc.date.available2015-11-24T18:54:45Z
dc.identifier.issn0304-3835-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18736
dc.rightsDefault Licence-
dc.subjectAdaptation, Biologicalen
dc.subjectCysteine/metabolismen
dc.subjectHumansen
dc.subjectHydrogen Peroxide/pharmacologyen
dc.subjectIron/*metabolismen
dc.subjectMutationen
dc.subjectNeoplasms/etiology/*metabolismen
dc.subjectOxidation-Reductionen
dc.subjectOxidative Stressen
dc.subjectReactive Oxygen Species/*metabolismen
dc.subject*Signal Transductionen
dc.titleRedox signaling and cancer: the role of "labile" ironen
heal.abstractReactive oxygen species (ROS) were viewed for a long time as unavoidable by-products of normal cell catabolism. This view has recently changed and it is now apparent that ROS generation is a tightly regulated process that plays a central role in cell signaling. Thus, it is known that regulated changes in intracellular ROS levels can induce biochemical signaling processes that control basic cellular functions, such as proliferation and apoptosis which are prevalent in the development of cancer. In this short review, we will try to provide a background to this emerging field by summarizing the biochemistry of ROS-mediated cell signaling and its relation to carcinogenesis. Special emphasis will be focused on the emerging role of the so called "labile" iron (the redox-active form of iron) in ROS-mediated signaling in relation to cancer development. It is tempting to speculate that elucidation of the exact molecular mechanisms that govern ROS-mediated regulation of cell signaling will provide the basis for development of new therapeutic strategies for cancer prevention and treatment.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1016/j.canlet.2008.02.038-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/18374479-
heal.identifier.secondaryhttp://www.sciencedirect.com/science/article/pii/S0304383508001407-
heal.journalNameCancer Letten
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2008-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: